Willis Investment Counsel’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34M Sell
392,048
-5,205
-1% -$499K 1.86% 17
2025
Q4
$38.2M Sell
397,253
-4,615
-1% -$448K 1.97% 10
2025
Q3
$38.3M Buy
401,868
+19,192
+5% +$1.76M 2.09% 11
2025
Q2
$33.4M Buy
382,676
+30,138
+9% +$2.56M 1.95% 12
2025
Q1
$31.7M Sell
352,538
-1,149
-0.3% -$103K 2.13% 11
2024
Q4
$28.3M Buy
353,687
+1,837
+0.5% +$159K 1.85% 16
2024
Q3
$31.7M Buy
351,850
+990
+0.3% +$83.3K 2.06% 12
2024
Q2
$27.6M Buy
350,860
+323
+0.1% +$26.5K 1.91% 14
2024
Q1
$30.5M Buy
350,537
+1,730
+0.5% +$148K 2.1% 12
2023
Q4
$28.7M Sell
348,807
-803
-0.2% -$61.2K 2.02% 14
2023
Q3
$27.4M Sell
349,610
-37,845
-10% -$3.17M 2.07% 13
2023
Q2
$34.1M Sell
387,455
-89
-0% -$7.66K 2.23% 9
2023
Q1
$31.2M Buy
387,544
+3,104
+0.8% +$253K 2.04% 12
2022
Q4
$29.9M Sell
384,440
-3,446
-0.9% -$279K 1.91% 14
2022
Q3
$31.3M Sell
387,886
-34,282
-8% -$3.08M 2.27% 8
2022
Q2
$37.9M Sell
422,168
-2,627
-0.6% -$266K 2.32% 8
2022
Q1
$47.1M Buy
424,795
+5,774
+1% +$610K 2.49% 7
2021
Q4
$43.3M Buy
419,021
+24,910
+6% +$2.88M 2.28% 10
2021
Q3
$49.4M Buy
394,111
+26,624
+7% +$3.45M 2.82% 5
2021
Q2
$45.6M Buy
367,487
+19,391
+6% +$2.43M 2.7% 8
2021
Q1
$41.1M Sell
348,096
-1,045
-0.3% -$122K 2.5% 9
2020
Q4
$40.9M Sell
349,141
-32,803
-9% -$3.61M 2.8% 4
2020
Q3
$39.7M Buy
381,944
+20,696
+6% +$2.08M 3.56% 1
2020
Q2
$33.1M Sell
361,248
-2,294
-0.6% -$220K 2.57% 4
2020
Q1
$32.8M Buy
363,542
+53,377
+17% +$5.68M 2.72% 6
2019
Q4
$35.2M Buy
310,165
+227
+0.1% +$24.9K 2.28% 6
2019
Q3
$33.7M Buy
309,938
+22,126
+8% +$2.31M 2.25% 5
2019
Q2
$28M Buy
287,812
+1,112
+0.4% +$102K 1.9% 10
2019
Q1
$23.8M Buy
286,700
+15,974
+6% +$1.43M 1.64% 13
2018
Q4
$24.6M Sell
270,726
-1,964
-0.7% -$184K 1.83% 6
2018
Q3
$26.8M Buy
272,690
+81,151
+42% +$7.5M 1.85% 7
2018
Q2
$16.4M Buy
191,539
+19,296
+11% +$1.61M 1.21% 33
2018
Q1
$13.8M Buy
172,243
+74,710
+77% +$6.16M 1.07% 39
2017
Q4
$7.88M Sell
97,533
-49
-0.1% -$3.92K 0.55% 76
2017
Q3
$7.59M Sell
97,582
-379
-0.4% -$31.5K 0.55% 76
2017
Q2
$8.69M Buy
97,961
+296
+0.3% +$25K 0.66% 69
2017
Q1
$7.87M Buy
97,665
+2,325
+2% +$182K 0.59% 65
2016
Q4
$6.79M Buy
95,340
+446
+0.5% +$35K 0.51% 77
2016
Q3
$8.2M Buy
94,894
+1,136
+1% +$99K 0.66% 65
2016
Q2
$8.13M Buy
93,758
+50
+0.1% +$4.04K 0.69% 68
2016
Q1
$7.03M Buy
93,708
+914
+1% +$68.8K 0.62% 72
2015
Q4
$7.14M Buy
92,794
+100
+0.1% +$7.53K 0.65% 69
2015
Q3
$6.21M Buy
92,694
+7,799
+9% +$574K 0.61% 78
2015
Q2
$6.29M Sell
84,895
-4,679
-5% -$357K 0.6% 76
2015
Q1
$6.99M Buy
89,574
+590
+0.7% +$44.7K 0.65% 76
2014
Q4
$6.42M Sell
88,984
-35,115
-28% -$2.44M 0.6% 77
2014
Q3
$7.69M Buy
124,099
+3,340
+3% +$212K 0.81% 54
2014
Q2
$7.7M Sell
120,759
-640
-0.5% -$38.9K 0.75% 57
2014
Q1
$7.48M Buy
121,399
+2,414
+2% +$141K 0.76% 58
2013
Q4
$6.83K Buy
118,985
+570
+0.5% +$32.3K 0.32% 59
2013
Q3
$6.09M Hold
118,415
0.7% 63
2013
Q2
$6.09M Buy
+118,415
New +$5.85M 0.7% 63

Other funds holding MDT

Willis Investment Counsel's MDT Position: Q1 2026 in Review

Willis Investment Counsel reduced its Medtronic (MDT) stake by 1.3% in Q1 2026, selling an estimated $499K and leaving 392,048 shares worth $34M. The position accounts for 1.86% of the portfolio, ranked #17.

Willis Investment Counsel first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $49.4M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Willis Investment Counsel held 392,048 shares of Medtronic worth $34M as of Q1 2026.
  • Willis Investment Counsel sold 5,205 Medtronic shares in Q1 2026, an estimated $499K.
  • Medtronic made up 1.86% of Willis Investment Counsel's portfolio in Q1 2026, its #17 holding.
  • Willis Investment Counsel first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Willis Investment Counsel's Medtronic position peaked at $49.4M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Willis Investment Counsel's 13F filing for Q1 2026, filed 5 May 2026.